BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19776690)

  • 1. The role of "metabolic memory" in the natural history of diabetes mellitus.
    Drzewoski J; Kasznicki J; Trojanowski Z
    Pol Arch Med Wewn; 2009; 119(7-8):493-500. PubMed ID: 19776690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications.
    Testa R; Bonfigli AR; Prattichizzo F; La Sala L; De Nigris V; Ceriello A
    Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?
    Ceriello A; Ihnat MA; Thorpe JE
    J Clin Endocrinol Metab; 2009 Feb; 94(2):410-5. PubMed ID: 19066300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis: the "metabolic memory", the new challenge of diabetes.
    Ceriello A
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S2-6. PubMed ID: 20115927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic memory - the implications for diabetic complications.
    Otto-Buczkowska E; Machnica L
    Endokrynol Pol; 2010; 61(6):700-3. PubMed ID: 21104645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging challenge in diabetes: the "metabolic memory".
    Ceriello A
    Vascul Pharmacol; 2012; 57(5-6):133-8. PubMed ID: 22609133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesis: the 'metabolic memory', the new challenge of diabetes.
    Ihnat MA; Thorpe JE; Ceriello A
    Diabet Med; 2007 Jun; 24(6):582-6. PubMed ID: 17490424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic memory: implications for diabetic vascular complications.
    Cooper ME
    Pediatr Diabetes; 2009 Aug; 10(5):343-6. PubMed ID: 19490497
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stress.
    Yaribeygi H; Atkin SL; Sahebkar A
    J Cell Physiol; 2019 Feb; 234(2):1300-1312. PubMed ID: 30146696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms.
    Tonna S; El-Osta A; Cooper ME; Tikellis C
    Nat Rev Nephrol; 2010 Jun; 6(6):332-41. PubMed ID: 20421885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of diabetes mellitus: could simultaneous targeting of hyperglycemia and oxidative stress be a better panacea?
    Erejuwa OO
    Int J Mol Sci; 2012; 13(3):2965-2972. PubMed ID: 22489136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic memory: mechanisms and implications for diabetic retinopathy.
    Zhang L; Chen B; Tang L
    Diabetes Res Clin Pract; 2012 Jun; 96(3):286-93. PubMed ID: 22209677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of xylo-oligosaccharides and fructo-oligosaccharides in streptozotocin-induced diabetic rats.
    Gobinath D; Madhu AN; Prashant G; Srinivasan K; Prapulla SG
    Br J Nutr; 2010 Jul; 104(1):40-7. PubMed ID: 20187988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic memory for vascular disease in diabetes.
    Aschner PJ; Ruiz AJ
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S68-74. PubMed ID: 22650227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: involvement of advanced glycosylated end products.
    Remor AP; de Matos FJ; Ghisoni K; da Silva TL; Eidt G; Búrigo M; de Bem AF; Silveira PC; de León A; Sanchez MC; Hohl A; Glaser V; Gonçalves CA; Quincozes-Santos A; Borba Rosa R; Latini A
    Biochim Biophys Acta; 2011 Nov; 1812(11):1460-71. PubMed ID: 21767639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.
    Meerwaldt R; Links T; Zeebregts C; Tio R; Hillebrands JL; Smit A
    Cardiovasc Diabetol; 2008 Oct; 7():29. PubMed ID: 18840258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful management of in-hospital hyperglycemia: the pivotal role of nurses in facilitating effective insulin use.
    Lange VZ
    Medsurg Nurs; 2010; 19(6):323-8. PubMed ID: 21337988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arjunolic acid: beneficial role in type 1 diabetes and its associated organ pathophysiology.
    Manna P; Sil PC
    Free Radic Res; 2012 Jul; 46(7):815-30. PubMed ID: 22486656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mechanisms of Inhibition of Advanced Glycation End Products Formation through Polyphenols in Hyperglycemic Condition.
    Khangholi S; Majid FA; Berwary NJ; Ahmad F; Aziz RB
    Planta Med; 2016 Jan; 82(1-2):32-45. PubMed ID: 26550791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.